FDA	U.S. Food and Drug Administration
CDER	immunohistochemistry
CBER	Center for Biologics Evaluation and Research
WHO	World Health Organization
mAb	Monoclonal antibody
bsAb	Bispecific antibody
ADC	Antibody-drug conjugate
CAR T	Chimeric antigen receptor T cell
AAV	adeno-associated virus
ON	Oligonucleotide
ASO	Antisense oligonucleotide
siRNA	Short interfering RNA
CRISPR	clustered regularly interspaced short palindromic repeats
PFS	Progression-free-survival
HER2	Human epidermal growth factor receptor 2
TNBC	Triple-negative breast cancer
BRCA	Breast cancer gene
NSCLC	Non-small lung cancer
SCLC	Small cell lung cancer
ASCT	Autologous stem cell transformation
PI	Proteasome inhibitor
IMiDs	Immunomodulatory drugs
DEX	Dexamethasone
NDMM	Newly-diagnosed multiple myeloma
RRMM	Relapsed/refractory myeloma
MRD	Minimal residual disease